• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Seno Medical Instruments

Seno Medical Instruments touts Imagio breast cancer subtype ID trial results

December 11, 2018 By Fink Densford

Seno Medical Instruments today released results from a study of its Imagio opto-acoustc imaging system intended to diagnose breast cancer, touting that both morphologic and functional OA/US features serve as a non-invasive approach to helping distinguish breast cancer molecular subtypes. Results from the study were presented late last month at the Radiological Society of North […]

Filed Under: Clinical Trials, Women's Health Tagged With: Seno Medical Instruments

Seno Medical touts Imagio analsyses data, looks to 2017 for PMA bid

December 9, 2016 By Fink Densford

Seno Medical Instruments today released data from 2 new analyses of a post-market study of its Imagio opto-acoustic technology designed to aid in the diagnosis of breast cancer, hoping to submit a Premarket Approval application to the FDA early next year. The Imagio system combines traditional ultrasound with light-based imaging, providing physicians with a closer look […]

Filed Under: Clinical Trials, Imaging, Regulatory/Compliance, Women's Health Tagged With: Seno Medical Instruments

Seno Medical grabs ex-CeloNova CFO Davis | Personnel Moves August 12, 2016

August 12, 2016 By Fink Densford

Seno Medical grabs ex-CeloNova CFO Davis Seno Medical Instuments said this week it tapped former CeloNova BioSciences chief financial officer Eric Davis to take over the CFO role at Seno Medical. Prior to his years at CeloNova, Davis operated as CFO and operating officer at Genesis Networks Enterprises. Seno Medical said that Davis has more than […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Business/Financial News Tagged With: Allergan, CeloNova BioSciences, Cerus Corp., CooperVision, Endologix, InVivo Therapeutics, Medtronic, Personnel Moves, ReVision Optics Inc., Seno Medical Instruments, TriVascular, UnitedHealth Group

Seno Medical touts data from Imagio breast cancer pilot study

December 23, 2015 By Fink Densford

Seno Medical Instruments on Monday released data from the pilot study portion of its Pioneer pivotal study examining its Imagio opto-acoustic tool designed to diagnose breast cancer. The company said data from the trial showed Imagio system improved physicians’ ability to classify benign breast masses when compared to traditional ultrasounds methods. Data from the 100-patient […]

Filed Under: Clinical Trials, Oncology, Women's Health Tagged With: Seno Medical Instruments

Seno Medical completes Imagio pivotal trial

October 2, 2015 By Fink Densford

Seno Medical said Tuesday it completed the final phase of the pivotal trial of its Imagio opto-acoustic breast imaging platform designed to help prevent unnecessary biopsies. The Imagio system combines traditional ultrasound with light-based imaging, providing physicians with a closer look at “suspicious” breast masses without subjecting patients to radiation, injectable contrast agents or invasive […]

Filed Under: Clinical Trials, Imaging, Mammography, Women's Health Tagged With: Seno Medical Instruments

Ex-Medtronic strategy veep Oesterle joins VC shop New Enterprise Associates | Personnel Moves

September 10, 2015 By Fink Densford

Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, […]

Filed Under: Business/Financial News Tagged With: Allergan, Boston Scientific, Ceterix Orthopaedics, cyberonics, Evolent Health, iCad Inc., Intronix, Iridex Corp., Johnson and Johnson, LeMaitre Vascular Inc., LivaNova, Medtronic, New Enterprise Associates, Personnel Moves, Seno Medical Instruments, Sorin Group, STAAR Surgical Co, VisionCare Ophthalmic Technologies, Zoll Medical

Update: Seno Medical closing in on funding goal, now at $35M

February 26, 2014 By Chris Walker Leave a Comment

Update: Seno Medical closing in on funding goal, now at $35M

Seno Medical is inching to its $39 million fundraising objective, having brought in $34.6 million in its Series C equity funding round.

San Antonio-based Seno has been at this for some time, and for this round has brought in MedCare Investment Funds as a lead investor. The funding is going towards the company’s U.S. pivotal study of the Imagio breast imaging device, as well as chasing CE Mark approval in Europe.

Filed Under: Funding Roundup, News Well, Oncology Tagged With: Breast Cancer, Seno Medical Instruments

Breast cancer: Seno Medical hits 100th patient in Imagio pivotal trial

November 25, 2013 By Arezu Sarvestani Leave a Comment

Breast cancer: Seno Medical hits 100th patient in Imagio imaging trial

Seno Medical Instruments touted the 100th patient enrolled in a pivotal clinical study of the company’s Imagio system, an opto-acoustic breast imaging platform designed to help prevent unnecessary biopsies.

Filed Under: News Well, Oncology, Women's Health Tagged With: Breast Cancer, Clinical Trials, Seno Medical Instruments

Seno Medical Instruments raises $15M

November 14, 2012 By MassDevice staff Leave a Comment

Seno Medical Instruments

Seno Medical Technologies raised $14.5 million in an equity round from 28 unnamed investors, according to a regulatory filing.

The San Antonio, Texas-based medical device company is developing opto-acoustic imaging technology to locate cancerous tumors in breast tissue.

Filed Under: Funding Roundup, News Well, Oncology Tagged With: Breast Cancer, Seno Medical Instruments

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy